by Grillon C, Krishtel PR, Mellouk O, Basenko A, Freeman J, Mendão L, Andrieux-Meyer I, Morin S.
Journal of the International Aids Society, April 2018
Bogotá, Colombia – 14 April 2018
Objective is to improve access to diagnosis and treatment of people affected by this disease
An agreement to facilitate and strengthen access to diagnosis and treatment of patients with Chagas and other diseases of public health interest has been signed by the Colombian Ministry of Health and Social Protection and the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi).
Buenos Aires, Argentina – 13 April 2018
Argentina has approved the paediatric indication of a drug used for treatment of Chagas disease, benznidazole, which will now be available in 12.5 mg pills, the dose required to treat children under the age of 2. The indication was approved by the Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT).
1-6 July 2018
Kyoto, Japan
Tatsuro Kuzuki, Scientific Liaison, DNDi Japan – session on NTDs
17-19 April 2018
Basel, Switzerland
Nathalie Strub-Wourgraft, DNDi Medical Director – Member of multi-stakeholder panel: “Towards access 2030: How can strengthening of regulatory systems contribute?”